|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2010-6-15
|
|
pubmed:abstractText |
Little is known about the efficacy and safety of infliximab for ulcerative colitis refractory to tacrolimus. The aim of this study was to evaluate the efficacy and safety of infliximab in the induction of remission in ulcerative colitis patients with persistent symptoms despite tacrolimus therapy.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
1440-1746
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
25
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
886-91
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:20546441-Adolescent,
pubmed-meshheading:20546441-Adrenal Cortex Hormones,
pubmed-meshheading:20546441-Adult,
pubmed-meshheading:20546441-Aged,
pubmed-meshheading:20546441-Anti-Inflammatory Agents,
pubmed-meshheading:20546441-Antibodies, Monoclonal,
pubmed-meshheading:20546441-Colectomy,
pubmed-meshheading:20546441-Colitis, Ulcerative,
pubmed-meshheading:20546441-Drug Resistance,
pubmed-meshheading:20546441-Female,
pubmed-meshheading:20546441-Gastrointestinal Agents,
pubmed-meshheading:20546441-Humans,
pubmed-meshheading:20546441-Immunosuppressive Agents,
pubmed-meshheading:20546441-Infusions, Intravenous,
pubmed-meshheading:20546441-Japan,
pubmed-meshheading:20546441-Kaplan-Meier Estimate,
pubmed-meshheading:20546441-Male,
pubmed-meshheading:20546441-Middle Aged,
pubmed-meshheading:20546441-Remission Induction,
pubmed-meshheading:20546441-Retrospective Studies,
pubmed-meshheading:20546441-Severity of Illness Index,
pubmed-meshheading:20546441-Tacrolimus,
pubmed-meshheading:20546441-Time Factors,
pubmed-meshheading:20546441-Treatment Outcome,
pubmed-meshheading:20546441-Young Adult
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Efficacy and safety of infliximab as rescue therapy for ulcerative colitis refractory to tacrolimus.
|
|
pubmed:affiliation |
Department of Gastroenterology and Hepatology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
